title: Sequential high-dose combination chemotherapy with granulocyte colony-stimulating factor and peripheral blood progenitor cells in patients with solid tumors: intensification limited by nonhematologic toxic effects.
authors.forename: S
authors.initials: S
authors.lastname: Leyvraz
authors.forename: N
authors.initials: N
authors.lastname: Ketterer
authors.forename: P
authors.initials: P
authors.lastname: Vuichard
authors.forename: V
authors.initials: V
authors.lastname: von Fliedner
authors.forename: F
authors.initials: F
authors.lastname: Lejeune
authors.forename: P
authors.initials: P
authors.lastname: Schneider
authors.forename: J P
authors.initials: JP
authors.lastname: Grob
authors.forename: F
authors.initials: F
authors.lastname: Bachmann
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001855:Bone Marrow Diseases / Q000517:prevention & control*; D004427:Ear Diseases / Q000139:chemically induced*; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D009422:Nervous System Diseases / Q000139:chemically induced*; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D000069585:Filgrastim